This review compares the pharmacology, spectrum of antifungal activity, pharmacokinetic
and pharmacodynamic properties, safety and clinical efficacy of the three licensed …

ABSTRACT Introduction: Invasive fungal diseases (IFDs) are a leading cause of morbidity
and mortality among immunocompromised patients with bone marrow failure syndromes …

Abstract The European Society for Clinical Microbiology and Infectious Diseases, the
European Confederation of Medical Mycology and the European Respiratory Society Joint …

These guidelines were developed jointly by the American Society of Health-System
Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Surgical …

Scope Presenting symptoms, distributions and patterns of diseases and vulnerability to
invasive aspergillosis (IA) are similar between children and adults. However, differences …

D. Neofytos, JA Fishman, D. Horn, E. Anaissie, C.‐H. Chang, A. Olyaei, M. Pfaller, WJ
Steinbach, KM Webster, KA Marr. Epidemiology and outcome of invasive fungal infections in …

Solid organ transplant (SOT) recipients have a significant risk of invasive fungal diseases
(IFD) caused mainly by Candida spp. and Aspergillus spp. Candida spp. is the most frequent …

Fungal infections are rising all over the world every year. There are only five medical
compound classes for treatment: triazoles, echinocandins, polyenes, flucytosine and …

These updated guidelines from the American Society of Transplantation Infectious Diseases
Community of Practice provide recommendations for the diagnosis and management of …

Invasive fungal infections are a major problem in solid organ transplant (SOT) recipients.
Overall, the most common fungal infection in SOT is candidiasis, followed by aspergillosis …